Structure-activity relationships of retinoids in developmental toxicology. IV. Planar Cisoid conformational restriction.
暂无分享,去创建一个
[1] G. Frenking,et al. Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids. , 1989, Journal of medicinal chemistry.
[2] C C Willhite,et al. Dose response and structure-activity considerations in retinoid-induced dysmorphogenesis. , 1989, Critical reviews in toxicology.
[3] M. Wiley,et al. A comparative study of the effects of retinoic acid given during the critical period for inducing spina bifida in mice and hamsters. , 1988, Teratology.
[4] W. B. Howard,et al. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid. , 1987, Teratology.
[5] C. Willhite,et al. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids). , 1987, Journal of the National Cancer Institute.
[6] J. Tousignant,et al. Treatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298. , 1987, Journal of the American Academy of Dermatology.
[7] B. Helpap,et al. Sirenomelia and anencephaly in one of dizygotic twins. , 1986, Teratology.
[8] C. Willhite,et al. Morphogenesis of isotretinoin-induced microcephaly and micrognathia studied by scanning electron microscopy. , 1986, Teratology.
[9] A. Kistler. Structure-activity relationship of retinoids on lobuloalveolar differentiation of cultured mouse mammary glands. , 1986, Carcinogenesis.
[10] Y. Hashimoto,et al. Differentiation inducers of human promyelocytic leukemia cells HL-60. Phenylcarbamoylbenzoic acids and polyene amides. , 1986, Chemical & pharmaceutical bulletin.
[11] N. Lowe,et al. A comparative study of the induction of epidermal hyperplasia by natural and synthetic retinoids. , 1986, The Journal of pharmacology and experimental therapeutics.
[12] W. B. Howard,et al. Toxicity of Retinoids in Humans and Animals , 1986 .
[13] Hill Rm,et al. Isotretinoin-induced craniofacial malformations in humans and hamsters. , 1986 .
[14] D. Hilbelink,et al. Sirenomelia: analysis in the cadmium- and lead-treated golden hamster. , 1986, Teratogenesis, carcinogenesis, and mutagenesis.
[15] P. Fernhoff,et al. Retinoic acid embryopathy. , 1985, The New England journal of medicine.
[16] M. Sporn,et al. Retinoids and Differentiation of Cells of Mesenchymal Origin , 1985 .
[17] W. Bollag. New Retinoids with Potential Use in Humans , 1985 .
[18] E. M. Holt,et al. Synthesis and characterization of selected heteroarotinoids. Pharmacological activity as assessed in vitamin A deficient hamster tracheal organ cultures. Single-crystal X-ray diffraction analysis of 4,4-dimethylthiochroman-6-yl methyl ketone 1,1-dioxide and ethyl (E)-p-[2-(4,4-dimethylthiochroman-6- , 1985, Journal of medicinal chemistry.
[19] N. van Regemorter,et al. A case of partial sirenomelia and possible vitamin A teratogenesis , 1985, Prenatal diagnosis.
[20] J. Gruber,et al. Conformationally restricted retinoids. , 1984, Journal of medicinal chemistry.
[21] W. B. Howard,et al. Structure-Activity Relationships of Retinoids in Developmental Toxicology , 1984 .
[22] N. Lowe,et al. Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids. , 1984, The Journal of investigative dermatology.
[23] G M Schoofs,et al. A probit analysis program for the personal computer , 1984, Journal of applied toxicology : JAT.
[24] C. Willhite,et al. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids. , 1984, Journal of the National Cancer Institute.
[25] P. Fritsch,et al. Response of Psoriatic Arthropathy to Arotinoid (Ro 13-6298): A Pilot Study , 1984 .
[26] M. Dawson,et al. Relationship between binding affinities to cellular retinoic acid-binding protein and biological potency of a new series of retinoids. , 1984, Cancer research.
[27] G. Mahrle,et al. Chemotherapie kutaner T-Zell-Lymphome mit Arotinoid , 1983, Deutsche medizinische Wochenschrift.
[28] W. Kueng,et al. Sulfur-containing arotinoids, a new class of retinoids , 1984 .
[29] M. Dawson,et al. Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids. , 1983, Journal of medicinal chemistry.
[30] M. Sporn,et al. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. , 1983, Cancer research.
[31] C. Orfanos,et al. Antipsoriatic activity of a new synthetic retinoid. The arotinoid RO 13-6298. , 1983, Archives of dermatology.
[32] M. Dawson,et al. Aromatic retinoic acid analogues. 2. Synthesis and pharmacological activity. , 1983, Journal of medicinal chemistry.
[33] M. Taketo,et al. Effects of arotinoids upon murine embryonal carcinoma cells. , 1983, Cancer research.
[34] M. Sporn,et al. Structure-activity relationships of retinoids in hamster tracheal organ culture. , 1980, Cancer research.
[35] P. Loeliger,et al. AROTINOIDS, A NEW CLASS OF HIGHLY ACTIVE RETINOIDS , 1980 .
[36] E. Giavini,et al. The extent of fetal ossification as an index of delayed development in teratogenic studies on the rat. , 1979, Teratology.